13 research outputs found
Switching Reversibility to Irreversibility in Glycogen Synthase Kinase 3 Inhibitors: Clues for Specific Design of New Compounds
Facile Synthesis of Gold(III) ArylāCarbene Metallacycles
New goldĀ(III) metallacyclic complexes with unprecedented
arylācarbene bidentate ligands have been prepared by the reaction
of the cycloaurated goldĀ(III) complex [AuCl<sub>2</sub>(pap-C<sup>1</sup>,N)] (pap = 2-(2-pyridylamino)Āphenyl) with isocyanide CNR
(R = 2-naphthyl (<b>1</b>), cyclohexyl (<b>2</b>), or
2,6-dimethylphenyl (<b>3</b>)). Complexes have been spectroscopically
and structurally characterized, showing in some complexes aurophilic
goldĀ(III)Ā·Ā·Ā·goldĀ(III) and ĻāĻ interactions.
In contrast with the starting material these complexes are emissive
in the solid state, probably because of the better Ļ-donor properties
of the new bidentate ligands
New Tacrineā4-Oxo-4<i>H</i>-chromene Hybrids as Multifunctional Agents for the Treatment of Alzheimerās Disease, with Cholinergic, Antioxidant, and Ī²-Amyloid-Reducing Properties
By using fragments endowed with interesting and complementary
properties
for the treatment of Alzheimerās disease (AD), a new family
of tacrineā4-oxo-4<i>H</i>-chromene hybrids has been
designed, synthesized, and evaluated biologically. The tacrine fragment
was selected for its inhibition of cholinesterases, and the flavonoid
scaffold derived from 4-oxo-4<i>H</i> -chromene was chosen
for its radical capture and Ī²-secretase 1 (BACE-1) inhibitory
activities. At nano- and picomolar concentrations, the new tacrineā4-oxo-4<i>H</i>-chromene hybrids inhibit human acetyl- and butyrylcholinesterase
(h-AChE and h-BuChE), being more potent than the parent inhibitor,
tacrine. They are also potent inhibitors of human BACE-1, better than
the parent flavonoid, apigenin. They show interesting antioxidant
properties and could be able to penetrate into the CNS according to
the in vitro PAMPA-BBB assay. Among the hybrids investigated, 6-hydroxy-4-oxo- <i>N</i>-{10-[(1,2,3,4-tetrahydroacridin-9-yl)Āamino]Ādecyl}-4 <i>H</i>-chromene-2-carboxamide (<b>19</b>) shows potent
combined inhibition of human BACE-1 and ChEs, as well as good antioxidant
and CNS-permeable properties
Calidad de planta de Cedrela odorata L. asociada con praĢcticas culturales de vivero
En MeĢxico muchas reforestaciones con Cedrela odorata no han tenido un desempenĢo inicial favorable, principalmente por el uso de planta de baja calidad, por lo que se requieren de alternativas en los viveros forestales que mejoren dicha condicioĢn. En el presente trabajo fue examinada la influencia del volumen de envase e hidrogel sobre la morfologiĢa, estado nutrimental y desempenĢo en campo de plaĢntulas de C. odorata. El volumen del envase se manejoĢ a dos niveles: bolsa de polietileno de 500 mL y tubete de plaĢstico de 380 mL; el hidrogel, con tres niveles: adicioĢn de 0, 2 y 4 g L-1 de sustrato. Las caracteriĢsticas de las plaĢntulas se evaluaron en vivero, mediante la determinacioĢn de varios indicadores morfoloĢgicos de calidad de planta y el uso de nomogramas de anaĢlisis de vectores para el diagnoĢstico del estado del nitroĢgeno, foĢsforo y potasio. El desempenĢo en campo fue medido como supervivencia y crecimiento durante 17 meses, a partir del establecimiento de la plantacioĢn. Las plaĢntulas con los mejores atributos fueron las producidas en envases de 500 mL con la adicioĢn de hidrogel al sustrato en dosis de 4 g L-1; no obstante, el mejor desempenĢo en campo correspondioĢ a las producidas en envases de 500 mL sin hidrogel, lo que permite concluir que el volumen de envase tiene un efecto directo en la calidad de planta de C. odorata
New Melatoninā<i>N</i>,<i>N</i>āDibenzyl(<i>N</i>āmethyl)amine Hybrids: Potent Neurogenic Agents with Antioxidant, Cholinergic, and Neuroprotective Properties as Innovative Drugs for Alzheimerās Disease
Here, we describe a new family of
melatoninā<i>N</i>,<i>N</i>-dibenzylĀ(<i>N</i>-methyl)Āamine hybrids
that show a balanced multifunctional profile covering neurogenic,
antioxidant, cholinergic, and neuroprotective properties at low-micromolar
concentrations. They promote maturation of neural stem cells into
a neuronal phenotype and thus they could contribute to CNS repair.
They also protect neural cells against mitochondrial oxidative stress,
show antioxidant properties, and inhibit human acetylcholinesterase
(AChE). Moreover, they displace propidium from the peripheral anionic
site of AChE, preventing the Ī²-amyloid aggregation promoted
by AChE. In addition, they show low cell toxicity and can penetrate
into the CNS. This multifunctional profile highlights these melatoninā<i>N</i>,<i>N</i>-dibenzylĀ(<i>N</i>-methyl)Āamine
hybrids as useful prototypes in the research of innovative drugs for
Alzheimerās disease
Structural Investigation of Weak Intermolecular Interactions (Hydrogen and Halogen Bonds) in Fluorine-Substituted Benzimidazoles
The
structures of five fluorinated benzimidazoles and one intermediate
(an open double amide) have been determined by X-ray crystallography.
In the analysis of these heterocycles, particular attention has been
paid to NāHĀ·Ā·Ā·H hydrogen bonds and to fluorineāfluorine
intermolecular contacts. Thus, one of the shortest FĀ·Ā·Ā·F
distances ever reported, 2.596(3) Ć
, has been observed in 4,5,6,7-tetrafluoro-1<i>H</i>-benzimidazole-2Ā(3<i>H</i>)-one. The <sup>13</sup>C, <sup>15</sup>N, and <sup>19</sup>F solid-state NMR data for all
benzimidazoles are also given
New Acridine Thiourea Gold(I) Anticancer Agents: Targeting the Nucleus and Inhibiting Vasculogenic Mimicry
Two new 1-acridin-9-yl-3-methylthiourea
AuĀ(I) DNA intercalators
[AuĀ(ACRTU)<sub>2</sub>]Cl (<b>2</b>) and [AuĀ(ACRTU) (PPh<sub>3</sub>)]ĀPF<sub>6</sub> (<b>3</b>) have been prepared. Both
complexes were highly active in the human ovarian carcinoma cisplatin-sensitive
A2780 cell line, exhibiting IC<sub>50</sub> values in the submicromolar
range. Compounds <b>2</b> and <b>3</b> are also cytotoxic
toward different phenotypes of breast cancer cell lines MDA-MB-231
(triple negative), SK-BR-3 (HER2+, ERĪ±ā, and ERĪ²ā),
and MCF-7 (ER+). Both complexes induce apoptosis through activation
of caspase-3 <i>in vitro.</i> While inhibition of some proteins
(thiol-containing enzymes) seems to be the main mechanism of action
for cytotoxic gold complexes, <b>2</b> and <b>3</b> present
a DNA-dependent mechanism of action. They locate in the cell nucleus
according to confocal microscopy and transmission electronic microscopy.
The binding to DNA resulted to be <i>via</i> intercalation
as shown by spectroscopic methods and viscometry, exhibiting a dose-dependent
response on topoisomerase I mediated DNA unwinding. In addition, <b>2</b> and <b>3</b> exhibit potent antiangiogenic effects
and are also able to inhibit vasculogenic mimicry of highly invasive
MDA-MB-231 cells
New Acridine Thiourea Gold(I) Anticancer Agents: Targeting the Nucleus and Inhibiting Vasculogenic Mimicry
Two new 1-acridin-9-yl-3-methylthiourea
AuĀ(I) DNA intercalators
[AuĀ(ACRTU)<sub>2</sub>]Cl (<b>2</b>) and [AuĀ(ACRTU) (PPh<sub>3</sub>)]ĀPF<sub>6</sub> (<b>3</b>) have been prepared. Both
complexes were highly active in the human ovarian carcinoma cisplatin-sensitive
A2780 cell line, exhibiting IC<sub>50</sub> values in the submicromolar
range. Compounds <b>2</b> and <b>3</b> are also cytotoxic
toward different phenotypes of breast cancer cell lines MDA-MB-231
(triple negative), SK-BR-3 (HER2+, ERĪ±ā, and ERĪ²ā),
and MCF-7 (ER+). Both complexes induce apoptosis through activation
of caspase-3 <i>in vitro.</i> While inhibition of some proteins
(thiol-containing enzymes) seems to be the main mechanism of action
for cytotoxic gold complexes, <b>2</b> and <b>3</b> present
a DNA-dependent mechanism of action. They locate in the cell nucleus
according to confocal microscopy and transmission electronic microscopy.
The binding to DNA resulted to be <i>via</i> intercalation
as shown by spectroscopic methods and viscometry, exhibiting a dose-dependent
response on topoisomerase I mediated DNA unwinding. In addition, <b>2</b> and <b>3</b> exhibit potent antiangiogenic effects
and are also able to inhibit vasculogenic mimicry of highly invasive
MDA-MB-231 cells